• Home>
  • Stocks>
  • Thyrocare Technologies Ltd Share Price
Thyrocare Technologies Ltd share price logo

Thyrocare Technologies Ltd Share Price

(THYROCARE)

Small Cap

Healthcare Sector

₹890.25▲2.4%

as on 04:01PM, 29 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Thyrocare Technologies Ltd Performance

  • Day's Low

    Day's High

    ₹884.05
    Day's Price Range
    ₹919

  • 52 Week's Low

    52 Week's High

    ₹571.4
    52-Week Price Range
    ₹1,055
1 Month Return+ 26.38 %
3 Month Return+ 15.93 %
1 Year Return+ 40.18 %
Previous Close₹912.10
Open₹893.15
Volume1.15L
Upper Circuit₹1,094.50
Lower Circuit₹729.70
Market Cap₹4,833.53Cr

Thyrocare Technologies Ltd Fundamentals

P/E Ratio

52.84

PEG Ratio

13.76

Market Cap

₹4,833.53 Cr

P/B Ratio

6.54

EPS

13.12

Dividend Yield

3.04

Sector

Healthcare

ROE

13.75

Thyrocare Technologies Ltd Analyst Rating

based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts offering long term price targets for Thyrocare Technologies Ltd. An average target of ₹1007.5

Source: S&P Global Market Intelligence

Thyrocare Technologies Ltd Share analysis

Thyrocare Technologies Ltd price forecast by 2 analysts

Upside of10.46%

High

₹1015

Target

₹1007.50

Low

₹1000

Thyrocare Technologies Ltd target price ₹1007.5, a slight upside of 10.46% compared to current price of ₹890.25. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Key events for Thyrocare Technologies Ltd

  • Thyrocare Reports Strong Q4, Upgraded to BUY - 25 Apr, 2025

    Thyrocare Technologies posted a 24% YoY net profit increase in Q4FY25, with revenue rising 21%. ICICI Securities upgraded the stock to BUY, targeting Rs 1,000.

  • Thyrocare Reports Strong Q4 Earnings and Dividend - 24 Apr, 2025

    Thyrocare Technologies Ltd announced a 22% increase in Q4 net profit to Rs 21.7 crore and a 21.3% rise in revenue to Rs 187.2 crore. The board recommended a final dividend of Rs 21 per share for FY25, reflecting strong operational performance and growth in diagnostic tests.

  • Thyrocare Reports Strong Q4 Results and Dividend - 23 Apr, 2025

    Thyrocare Technologies announced a 21.9% rise in Q4 net profit and a ₹21 dividend. Consolidated net profit increased by 22.05%, with significant revenue growth. Overall, the company demonstrated strong financial performance in Q4 FY25.

  • Thyrocare Confirms SEBI Compliance for Q1 2025 - 08 Apr, 2025

    Thyrocare Technologies Limited has confirmed compliance with SEBI regulations, stating all shares are in dematerialized form with no rematerialization requests for Q1 2025. This ensures transparency and maintains investor confidence.

  • Thyrocare Technologies Announces Trading Window Closure - 27 Mar, 2025

    Thyrocare Technologies Ltd has announced the closure of its trading window from April 1, 2025, until 48 hours after its audited financial results for the fiscal year ending March 31, 2025. This action is in compliance with SEBI regulations on insider trading, ensuring transparency and adherence to regulatory standards.

Insights on Thyrocare Technologies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 12.75% to 12.97% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, THYROCARE stock has moved up by 14.7%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 11.49% to 11.56% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 169.93 Cr → 191.75 Cr (in ₹), with an average increase of 11.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 19.11 Cr → 21.7 Cr (in ₹), with an average increase of 11.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Fortis Healthcare Ltd has given 52.4% return, outperforming this stock by 12.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Max Healthcare Institute Ltd has given 165.8% return, outperforming this stock by 153.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 71.06% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.77% to 2.41% in Mar 2025 quarter

Thyrocare Technologies Ltd Financials

Value in ₹ crore
DetailsQ'1 24Q'2 24Q'3 24Q'4 24Q'1 25
Revenue₹154.25Cr (-)₹156.91Cr (↑1.72%)₹177.36Cr (↑13.03%)₹165.92Cr (↓6.45%)₹187.16Cr (↑12.80%)
Net Income₹17.18Cr (-)₹23.94Cr (↑39.35%)₹26.42Cr (↑10.36%)₹18.95Cr (↓28.27%)₹21.57Cr (↑13.83%)
Net Profit Margin11.14% (-)15.26% (↑36.98%)14.90% (↓2.36%)11.42% (↓23.36%)11.52% (↑0.88%)
Value in ₹ crore
Details2021202220232024
Total Assets₹529.30Cr (-)₹597.65Cr (↑12.91%)₹612.62Cr (↑2.50%)₹621.41Cr (↑1.43%)
Total Liabilities₹83.84Cr (-)₹76.95Cr (↓8.22%)₹91.58Cr (↑19.01%)₹107.60Cr (↑17.49%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹136.33Cr (-)₹111.07Cr (↓18.53%)₹105.68Cr (↓4.85%)₹120.02Cr (↑13.57%)₹155.19Cr (↑29.30%)

Thyrocare Technologies Ltd Index Inclusions

BSE Healthcare

₹42,211.90

-0.81 (▲-343.75%)

BSE Small-Cap

₹48,238.69

0.09 (▲45.23%)

Thyrocare Technologies Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
71.06%
0.00
Foreign Institutions
2.41%
0.00
Mutual Funds
12.97%
0.00
Retail Investors
11.56%
0.00
Others
2%
0.00

Thyrocare Technologies Ltd Key Indicators

Details20202021202220232024
Return On Assets %19.9421.3829.4710.5311.39
Details20202021202220232024
Book Value Per Share (₹)69.3980.8299.5497.3793.02
Details20202021202220232024
Earning Per Share (₹)16.7321.433.312.1613.12
Details20202021202220232024
Return On Equity %24.8829.0831.4810.9413.75

Thyrocare Technologies Ltd Valuation

Thyrocare Technologies Ltd in the last 5 years

  • Overview

  • Trends

Lowest (18.71x)

June 23, 2022

Today (52.84x)

April 28, 2025

Industry (101.14x)

April 28, 2025

Highest (91.79x)

October 27, 2020

LowHigh

Thyrocare Technologies Ltd Earnings and Dividends

  • Thyrocare Technologies Ltd Earnings Results

    Thyrocare Technologies Ltd’s net profit jumped 22.05% since last year same period to ₹21.70Cr in the Q4 2024-2025. On a quarterly growth basis, Thyrocare Technologies Ltd has generated 13.55% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Thyrocare Technologies Ltd Dividends May,2024

    In the quarter ending March 2024, Thyrocare Technologies Ltd has declared dividend of ₹18 - translating a dividend yield of 2.02%.

    Read More about Dividends

Thyrocare Technologies Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Thyrocare Technologies Ltd is currently in a Bullish trading position according to technical analysis indicators.

More on Technical Analysis

Thyrocare Technologies Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Thyrocare Technologies Ltd
Thyrocare Technologies Ltd
BUY₹4,833.53 Cr15.31%0.54₹69 Cr₹571 Cr
Vijaya Diagnostic Centre Ltd
Vijaya Diagnostic Centre Ltd
BUY₹10,656.72 Cr13.49%0.64₹119 Cr₹547 Cr
Metropolis Healthcare Ltd
Metropolis Healthcare Ltd
BUY₹8,968.04 Cr8.21%0.58₹128 Cr₹1,207 Cr
Dr Lal Pathlabs Ltd
Dr Lal Pathlabs Ltd
HOLD₹23,503.49 Cr15.68%0.55₹362 Cr₹2,226 Cr
Laurus Labs Ltd
Laurus Labs Ltd
HOLD₹33,784.17 Cr101.62%0.67₹168 Cr₹5,040 Cr
See all

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited was incorporated in 2000 and is one of the leading pan-India diagnostic chains, offering 636 distinct tests and 90 profiles of tests for early detection and management of various disorders and diseases. Additionally, they have set up Regional Processing Laboratories (RPLs) in 25 cities and Thryrocare International Holding Company (TIHC) in Mauritius has established a centre in Bahrain. In 2016, Thyrocare Technologies had a public offering that closed with an oversubscription of 75 times, and in 2018 acquired an Associate Company, Equinox Labs Private Limited, as well as bought back 958900 equity shares. In 2020, their services were negatively affected due to the Coronavirus, however, in 2021 they had a new promoter, Docon Technologies Private Limited, acquire 37656092 equity shares of the Company.As of March 31 2022, Thyrocare Technologies had a network of 1500 active channel partners and more than 9000 collection points spread across 500 districts in India and provided an extensive menu of over 700 tests, with more than 300 added within the year. Additionally, they installed automation for urine testing in 12 lab locations and Beckman Analysers in Zonal Processing Laboratories.

Revenue: ₹187.16Cr as on March 2025 (Q1 25)
Net Profit: ₹21.57Cr as on March 2025 (Q1 25)
Listing date: 09 May, 2016
Chairperson Name: Rahul Guha
OrganisationThyrocare Technologies Ltd
HeadquartersNavi Mumbai
IndustryHealthcare
E-voting on sharesClick here to vote

FAQs on Thyrocare Technologies Ltd

What is Thyrocare Technologies Ltd price today?

Thyrocare Technologies Ltd share price today stands at ₹890.25, Open: ₹893.15, Previous Close: ₹912.1, High: ₹919, Low: ₹884.05, 52 Week High: ₹1055, 52 Week Low: ₹571.4.

How to Buy Thyrocare Technologies Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Thyrocare Technologies Ltd shares

What are today's traded volumes of Thyrocare Technologies Ltd?

Today's traded volume of Thyrocare Technologies Ltd(THYROCARE) is 1.15L.

What is today's market capitalisation of Thyrocare Technologies Ltd?

Today's market capitalisation of Thyrocare Technologies Ltd(THYROCARE) is ₹4833.53Cr.

What is the 52 Week High and Low Range of Thyrocare Technologies Ltd?

Thyrocare Technologies Ltd (THYROCARE)
Price
52 Week High
₹1055
52 Week Low
₹571.4

How much percentage Thyrocare Technologies Ltd is down from its 52 Week High?

Thyrocare Technologies Ltd (THYROCARE) share price is ₹890.25. It is down -15.62% from its 52 Week High price of ₹1055

How much percentage Thyrocare Technologies Ltd is up from its 52 Week low?

Thyrocare Technologies Ltd (THYROCARE) share price is ₹890.25. It is up 55.80% from its 52 Week Low price of ₹571.4